Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/7/15 10:54 | 12/3/15 | CPXX | Health | Drug | Pharmaceutical Preparations | Morenstein Scott D | NY | D | P | 9 | 1.87 | 0 | 5 | 392 | 6 | D | -49 | -9 | -33 | -22 | 3 | 5 | 2 | -2 | -1 | -22 | 2 | -11 | 999 | ||
10/7/15 09:21 | 10/6/15 | CPXX | Health | Drug | Pharmaceutical Preparations | Jackson Scott Thomas | NJ | DO | CEO | P | 25 | 1.74 | 1 | 14 | 41 | 50 | D | -68 | -31 | -29 | -15 | -14 | -22 | -11 | 8 | 5 | -1 | 2 | 4 | 679 | |
10/5/15 16:05 | 10/5/15 | CPXX | Health | Drug | Pharmaceutical Preparations | Powell Fred M | NJ | O | VP,CFO | P | 24 | 1.78 | 1 | 14 | 77 | 31 | D | -71 | -33 | -30 | -24 | -21 | -29 | -21 | -2 | 3 | 7 | 3 | 5 | 638 | |
10/2/15 20:02 | 9/30/15 | CPXX | Health | Drug | Pharmaceutical Preparations | Valence Life Sciences Gp II LLC | NY | H | Member o | P.m | 20 | 1.64 | 1 | 12 | 1 | 1,296 | D | -71 | -34 | -33 | -23 | -25 | -33 | -23 | -26 | 2 | 9 | 6 | 5 | 595 | |
11/20/14 16:06 | 11/18/14 | CPXX | Health | Drug | Pharmaceutical Preparations | Dougherty Michael R | NJ | D | P | 43 | 2.15 | 0 | 20 | New | 20 | D | -43 | -19 | -26 | -22 | -9 | -10 | -4 | -4 | -6 | -8 | 43 | 17 | -13 | ||
11/18/14 16:01 | 11/18/14 | CPXX | Health | Drug | Pharmaceutical Preparations | Powell Fred M | NJ | O | CFO | P | 13 | 2.20 | 0 | 6 | 120 | 11 | D | -39 | -14 | -21 | -14 | -5 | -1 | 6 | -4 | -11 | -14 | 37 | 6 | -20 | |
11/18/14 16:00 | 11/18/14 | CPXX | Health | Drug | Pharmaceutical Preparations | Jackson Scott Thomas | NJ | DO | CEO | P | 22 | 2.20 | 0 | 10 | 333 | 13 | D | -39 | -14 | -21 | -14 | -5 | -1 | 6 | -4 | -11 | -14 | 37 | 6 | -20 | |
5/16/14 12:03 | 5/15/14 | CPXX | Health | Drug | Pharmaceutical Preparations | Powell Fred M | NJ | O | CFO | P | 6 | 2.50 | 0 | 3 | 100 | 5 | D | -30 | -17 | -19 | -13 | -8 | -4 | -1 | -1 | 17 | 6 | -19 | -10 | ||
12/17/13 16:10 | 12/17/13 | CPXX | Health | Drug | Pharmaceutical Preparations | Powell Fred M | NJ | O | VP,CFO | P | 9 | 3.50 | 0 | 3 | New | 3 | D | -37 | 7 | 0 | 0 | 3 | 3 | 3 | 7 | -2 | -13 | -45 | |||
12/17/13 16:07 | 12/17/13 | CPXX | Health | Drug | Pharmaceutical Preparations | Jackson Scott Thomas | NJ | DO | CEO | P | 10 | 3.50 | 0 | 3 | New | 3 | D | -37 | 7 | 0 | 0 | 3 | 3 | 3 | 7 | -2 | -13 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |